Frequent expression of human carcinoma-associated antigen, a mucin-type glycoprotein, in cells of prostatic carcinoma

Archives of Pathology and Laboratory Medicine

Volumn 128, Issue 12, 2004, Pages 1412-1417

  Li, Rongshan ^a   Yao, Jorge L ^a   Bourne, Patricia A ^a   Di Sant'Agnese, P Anthony ^a   Huang, Jiaoti ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; EPIGLYCANIN; GLYCOPROTEIN; HUMAN CARCINOMA ASSOCIATED ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY G1; MONOCLONAL ANTIBODY HAE3; MUCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATIC INTRAEPITHELIAL NEOPLASIA;

ANIMALS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; NEOPLASM STAGING; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 10344255712     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Thingstad T, Haavik S, Hansen K, Sletten K, Codington JF, Barsett H. Human carcinoma-associated antigen (HCA), isolated from the endometrial carcinoma cell line KLE-1 and ascitic fluid of a patient with ovarian carcinoma: comparison with epiglycanin. Eur J Pharm Sci. 1998;6:121-129.
2. Codington JF, Linsley KB, Jeanlot RW. Immunochemical and chemical investigations of the structure of glycoprotein fragments obtained from epiglycanin, a glycoprotein at the surface of the TA3-Ha cancer cell. Carbohydr Res. 1975;40:171-182.
3. Codington JF, Haavik S, Nikrui N, et al. Immunologic quantitation of the carcinoma specific human carcinoma antigen in clinical samples. Cancer 2002;94:803-813.
4. Codington JF, Bhavanandan VP, Bloch KJ, et al. Antibody to epiglycanin and radioimmunoassay to detect epiglycanin-related glycoproteins in body fluids of cancer patients. J Natl Cancer Inst. 1984;73:1029-1037.
5. Taylor JA, Goluboff ET, Holub W, et al. The human carcinoma antigen: a new biomarker for prostate cancer. J Urol. 1999;161(4, suppl):209.
6. Codington JF, Cooper AC, Miller DK, et al. Isolation and partial characterization of an epiglycanin-like glycoprotein from a new non-strain-specific subline of TA3 murine mammary adenocarcinoma. J Natl Cancer Inst. 1979;63:153-161.
7. Haavik S, Nilsen M, Thingstad T, et al. Specificity studies of an antibody developed against a mucin-type glycoprotein. Glycoconj J. 1999;16:229-236.
8. Gretzer MB, Partin AW. PSA markers in prostate cancer detection. Urol Clin North Am. 2003;30:677-686.
9. Fradet Y, Lockhart C, and Immunocyt™ trialists. Performance characteristics of a new monoclonal antibody test for bladder cancer: Immunocyt™. Can J Urol. 1997;4:400.
10. Dodd J, Tyler JP, Crandon AJ, et al. The value of the monoclonal antibody (cancer antigen 125) in serial monitoring of ovarian cancer: a comparison with circulating immune complexes. Br J Obstet Gynaecol. 1985;92:1054-1060.
11. Rasoul-Rockenschaub S, Zielinski CC, Kubista E, et al. Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer. Eur J Cancer Clin Oncol. 1989;25:1067-1072.